Grip Strength Test: What a Hand Dynamometer Measures and How to Read Your Result

A grip strength test measures the force you can produce while squeezing a hand dynamometer. It is quick, accessible and informative about muscular function, but it is not a diagnosis or a clock that can tell you how long you will live. Its value comes from using a consistent protocol, interpreting the score in the context of age, sex, height, pain and health, and deciding whether a low result or a true decline needs action.

Handgrip dynamometry is common in sarcopenia assessment, rehabilitation and population research because it is easy to repeat and relates to broader physical capability. It does not replace an examination, body composition, gait or functional tasks such as standing up from a chair. It is one part of the picture.

What a hand dynamometer actually measures

The dynamometer records the peak force of an isometric contraction: muscles produce tension without a large joint movement. The hand and forearm provide the force, but neural activation, pain, motivation, technique and overall capacity all influence the result.

It is therefore a practical marker of strength and functional reserve, not because the hand somehow represents the entire body. Painful arthritis, a tendon injury, carpal tunnel syndrome, previous stroke or a poorly adjusted handle can lower the score even when leg strength is good. Conversely, a climber may have exceptional grip without that number describing their whole cardiometabolic health.

Why grip strength is linked with future health

The PURE study analysed 139,691 adults aged 35–70 across 17 countries over a median of four years. Each 5 kg lower grip strength was associated with higher all-cause mortality —HR 1.16; 95% CI 1.13–1.20—, cardiovascular mortality —HR 1.17— and stroke —HR 1.09—. These were adjusted associations, not individual predictions or intervention effects.

A 2026 systematic review included 155 cohorts and meta-analysed 94. Compared with the lowest grip category, the highest category was associated with lower odds of subsequent cardiovascular disease —OR 0.73—, disability —OR 0.57— and dementia —OR 0.62—, among other outcomes. Yet cut-offs varied, heterogeneity was substantial for some outcomes, and certainty was low or very low for most findings; it was moderate for type 2 diabetes and dementia.

The responsible interpretation is that grip may help identify low functional reserve or a worsening trajectory. It does not show that a stronger hand directly causes protection. Illness, activity, nutrition, muscle mass, height and social factors can influence both grip and long-term risk.

How to perform a reproducible grip strength test

Several protocols are valid. Choose one linked to appropriate reference data and repeat it consistently. A common clinical approach is:

1. Use a reliable dynamometer adjusted to the hand. Record the make, model, handle position and units.
2. Sit with both feet supported. Keep the shoulder relaxed, elbow at about 90 degrees, forearm neutral and wrist neutral or slightly extended.
3. Squeeze maximally for about three seconds without holding your breath, leaning or bracing the device.
4. Test both hands. Perform three trials on each side, alternating hands and allowing roughly 30–60 seconds of recovery if fatigue is present.
5. Use the summary measure chosen beforehand. International norms often use the maximum; other protocols average three trials. Do not mix them.

Avoid testing immediately after demanding upper-body training, during acute hand pain or fever, or with a different instrument. For follow-up, test at a similar time and record dominance, pain, sleep, recent exercise and other relevant changes.

How to interpret a score without a magic table

Question	What to examine	What not to conclude
Is it broadly expected?	Age-, sex- and protocol-compatible percentile; height and reference population	That an above-average result removes other risks
Is strength low in an older adult?	EWGSOP2: <27 kg in men or <16 kg in women as a screen for possible sarcopenia	That the cut-off diagnoses sarcopenia by itself
Has it truly changed?	Same device and protocol; a repeated change of several kilograms plus functional context	That a one-off one- or two-kilogram shift is muscle loss
Is there a difference between hands?	Dominance, pain, injury, surgery and neurological symptoms	That every asymmetry is disease or that one universal percentage applies

International norms published in 2025 combined 2.4 million adults aged 20 to over 100 from 69 countries or territories. They show progressive decline with age and important differences by sex and testing method. A 2026 ELSA analysis of 7,658 English adults aged 50 or older also found wide ranges within each age group. Reference tables describe populations; they do not determine what should be normal for one person.

Sarcopenia cut-offs are not fitness targets

EWGSOP2 considers sarcopenia probable when low muscle strength is detected. Confirmation also requires low muscle quantity or quality, while poor physical performance indicates severity. A low score can therefore prompt assessment of sarcopenia, nutrition, illness and function; it should not label someone on its own.

DEXA or bioimpedance may add information on lean mass when the result changes a decision, but neither replaces a strength measure. Mass, strength and everyday capacity answer different questions.

When the result can change a decision

Situation	Reasonable next step	Timing
Expected score and stable function	Maintain whole-body strength, activity and adequate protein; avoid testing without a decision	Annual review or when context changes
Low score without urgent symptoms	Repeat correctly; review chair rise, gait, weight, intake, medication, pain and recent illness	Assessment over weeks, not self-diagnosis
Decline after hospitalisation, infection, immobility or weight loss	Look for the cause and build a recovery plan; consider physiotherapy and nutrition	Promptly; follow-up in 4–12 weeks according to risk
New asymmetry with pain or tingling	Musculoskeletal or neurological assessment	Within days; sooner if worsening
Sudden one-sided weakness, facial droop or speech change	Emergency assessment	Immediately

What can cause a low grip result

A low number does not identify one cause. It may reflect inactivity, muscle loss, inadequate energy or protein, pain, osteoarthritis, neuropathy, injury, anaemia, thyroid disease, cardiopulmonary illness, inflammation, medication effects or incomplete recovery after acute illness. In older adults, ask about falls, trouble opening containers, carrying bags, climbing stairs or getting up from a chair.

Unplanned weight loss, reduced intake, difficulty swallowing, repeated falls or rapid functional decline deserve clinical assessment. The score guides the conversation; the history determines what to investigate.

An 8–12 week plan to build strength, not just train the hand

The WHO recommends muscle-strengthening work for all major muscle groups on at least two days per week. A practical, adjustable starting point is:

• Two or three sessions each week, on non-consecutive days when possible.
• Five basic patterns: squat or chair rise, push, pull, hip hinge and loaded carry.
• One or two sets of 8–12 repetitions initially, progressing gradually while preserving technique. Frailty, pain or unstable illness may require a smaller, supervised start.
• Optional grip work: carries, dumbbell holds, finger extensors or adapted grips, always pain-free.
• Recovery and nutrition: adequate energy and protein for age, size, kidney health, activity and goals; there is no universal prescription from a blog.

A Cochrane review of 121 trials and 6,700 older participants found that progressive resistance training improves overall strength; across 73 studies and 3,059 people the effect was large —SMD 0.84. This does not mean every programme works equally or that raising a dynamometer score proves lower mortality. The purpose is to improve real capacity. Our guide to strength training during menopause shows how progression can be adapted during that life stage.

For follow-up, an approximate 3–5 kg change may exceed estimates of the minimal clinically important difference in healthy adults, but this depends on population and method. Repeat the same test and pair it with a functional task, symptoms and adherence. Do not train simply to game the device.

Limits and risks

• The test is sensitive to technique, motivation, fatigue, pain and calibration.
• Population ranges do not replace individual assessment.
• It does not diagnose sarcopenia, frailty, malnutrition, neurological disease or cardiovascular risk.
• Do not force the test with acute pain, recent hand or wrist surgery, or an unevaluated injury.
• A higher score may partly reflect familiarity; a lower one may reflect poor sleep, pain or recent training.

At Progevita, strength is interpreted as a trajectory: understand the context, measure with a reproducible method, integrate the result with body composition and capacity, then build a plan that can be reviewed. If you want to clarify what is worth measuring and what to prioritise, explore our personalised assessment programmes.

Sources

• Marín-Jiménez N et al. Clinical importance of simple muscular fitness tests to predict long-term health conditions: systematic review and meta-analysis of 94 cohort studies. Br J Sports Med. 2026. Article.
• Leong DP et al. Prognostic value of grip strength: findings from the PURE study. Lancet. 2015. Europe PMC.
• Cruz-Jentoft AJ et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019. EWGSOP2.
• Tomkinson GR et al. International norms for adult handgrip strength: data on 2.4 million adults. J Sport Health Sci. 2025. DOI.
• Roberts HC et al. A review of the measurement of grip strength: towards a standardised approach. Age Ageing. 2011. DOI.
• Bohannon RW. Minimal clinically important difference for grip strength: a systematic review. J Phys Ther Sci. 2019. PubMed.
• Grgic J et al. Reference values for gait speed, chair stand, balance and handgrip strength in ELSA. GeroScience. 2026. PubMed.
• Liu CJ, Latham NK. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev. Cochrane.
• World Health Organization. Physical activity recommendations. WHO.